Trial Profile

Phase 2 study of modified formulation of LIPO-202 in patients with central abdominal bulging

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 05 Feb 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Salmeterol (Primary)
Indications Subcutaneous fat disorders
Focus Adverse reactions; Therapeutic Use
Sponsors Evofem Biosciences; Neothetics

Most Recent Events

05 Feb 2018 Planned initiation date changed from 1 Jul 2016 to 1 Dec 2016.
17 Jan 2018 According to an Evofem Biosciences media release, Evofem Biosciences merged with Neothetics to form Evofem Biosciences
10 Nov 2016 According to a Neothetics media release, based on the results of a trial (see profile 269605) in patients with fat deposits under the chin (submental fat) company will initiate this study.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com